RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR - EFFECTS ON NORMAL AND LEUKEMIC MYELOID CELLS
RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR - EFFECTS ON NORMAL AND LEUKEMIC MYELOID CELLS
复制标题
DOI:
10.1126/science.2420009
复制
发表时间:
1986-04-04
期刊:
影响因子:
56.9
通讯作者:
WELTE, K
中科院分区:
文献类型:
--
作者:
SOUZA, LM;BOONE, TC;WELTE, K
Experiments were conducted to isolate and characterize the gene and gene product of a human hematopoietic colony-stimulating factor with pluripotent biological activities. This factor has the ability to induce differentiation of a murine myelomonocytic leukemia cell line WEHI-3B(D+) and cells from patients with newly diagnosed acute nonlymphocytic leukemia (ANLL). A complementary DNA copy of the gene encoding a pluripotent human granulocyte colony-stimulating factor (hG-CSF) was cloned and expressed in Escherichia coli. The recombinant form of hG-CSF is capable of supporting neutrophil proliferation in a CFU-GM assay. In addition, recombinant hG-CSF can support early erythroid colonies and mixed colony formation. Competitive binding studies done with 125I-labeled hG-CSF and cell samples from two patients with newly diagnosed human leukemias as well as WEHI-3(D+) cells showed that one of the human leukemia (ANLL, classifed as M4) and the WEHI-3B(D) cells have receptors for hG-CSF. Furthermore, the murine WEHI-3B(D+) cells and human leukemic cells classified as M2, M3, and M4 were induced by recombinant hG-CSF to undergo terminal differentiation to macrophages and granulocytes. The secreted form of the protein produced by the bladder carcinoma cell line 5637 was found to be O-glycosylated and to have a molecular weight of 19,600.